Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?
about
Targeting triple-negative breast cancer: optimising therapeutic outcomesPhosphorescence monitoring of hypoxic microenvironment in solid-tumors to evaluate chemotherapeutic effects using the hypoxia-sensitive iridium (III) coordination compoundEffects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo.The effect of 3β, 6β, 16β-trihydroxylup-20(29)-ene lupane compound isolated from Combretum leprosum Mart. on peripheral blood mononuclear cells.Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacyMetronomic chemotherapy: possible clinical application in advanced hepatocellular carcinomaRadiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease.Antitumor and immunomodulatory effects of low-dose 5-FU on hepatoma 22 tumor-bearing miceCombining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas.Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer.The antiangiogenic action of cisplatin on endothelial cells is mediated through the release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells
P2860
Q26850892-326958F6-3343-400D-9EA9-DF5C60116B9BQ28544651-0729E910-E1B2-4CF6-B825-F47FD271609BQ31050181-7DCDACEE-95D3-4763-8F2E-BD37A6A657D4Q35152542-D8D98BAF-EF47-4418-AB65-2262E1A9E67BQ35853383-151E2832-7C62-4088-A73E-F08976DC88E9Q36070256-60EE9A6D-60D3-4A96-B55A-325FCA9A19A3Q37236004-5A553155-A94F-459C-97EA-B1443C71DF62Q37520289-A1005F50-0E7D-42FC-BB72-D91AFFE4210AQ37728232-9478FD6C-F4E9-4ECF-9554-F4F4A40FF1FDQ38374526-6939DED3-9538-44FE-BA78-C501150601B9Q42734547-4D27D34B-EC83-412D-BD05-B4DFABD145D3Q50852560-70838B3F-486B-4EA7-9A8E-079154A9732DQ57821563-F8BA975D-B29A-4FC4-B02B-B9292D0E02FE
P2860
Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Low-dose metronomic chemothera ...... in H22 hepatocarcinoma cells?
@en
Low-dose metronomic chemothera ...... in H22 hepatocarcinoma cells?
@nl
type
label
Low-dose metronomic chemothera ...... in H22 hepatocarcinoma cells?
@en
Low-dose metronomic chemothera ...... in H22 hepatocarcinoma cells?
@nl
prefLabel
Low-dose metronomic chemothera ...... in H22 hepatocarcinoma cells?
@en
Low-dose metronomic chemothera ...... in H22 hepatocarcinoma cells?
@nl
P2093
P2860
P1476
Low-dose metronomic chemothera ...... in H22 hepatocarcinoma cells?
@en
P2093
Fang-Zhen Shen
Ji-Yuan Hou
Yan-Tao Wang
P2860
P356
10.1111/J.1365-2613.2009.00684.X
P577
2010-02-01T00:00:00Z